Structure Therapeutics In...
(GPCR)
undefined
undefined%
At close: undefined
31.29
0.33%
After-hours Dec 13, 2024, 05:46 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Revenue | - | - | - | - |
Cost of Revenue | 949.17K | 623.26K | 266.35K | 20.03K |
Gross Profit | -949.17K | -623.26K | -266.35K | -20.03K |
Operating Income | -102.78M | -52.56M | -37.70K | -15.91K |
Interest Income | 13.38M | 1.26M | 122.00 | 168.29K |
Pretax Income | -89.38M | -51.30M | -37.82K | -15.74K |
Net Income | -89.62M | -51.32M | -38.05K | -15.88K |
Selling & General & Admin | 32.67M | 16.37M | 8.59K | 3.54K |
Research & Development | 70.10M | 36.19M | 29.11K | 12.36K |
Other Expenses | 0.00 | - | - | - |
Operating Expenses | 102.78M | 52.56M | 37.70K | 15.91K |
Interest Expense | 13.39M | - | 122.16K | - |
Selling & Marketing Expenses | - | - | - | - |
Cost & Expenses | 102.78M | 52.56M | 37.70K | 15.91K |
Income Tax | 236.00K | 17.00K | 231.00 | 138.00 |
Shares Outstanding (Basic) | 36.73M | 36.59M | 36.59M | 36.59M |
Shares Outstanding (Diluted) | 36.73M | 36.59M | 36.59M | 36.59M |
EPS (Basic) | -2.44 | -1.4 | -0.00 | -0.00 |
EPS (Diluted) | -2.44 | -1.4 | -0.00 | -0.00 |
EBITDA | -102.78M | -52.28M | -37.62M | -15.75M |
Depreciation & Amortization | 316.00K | 623.26K | 266.35K | 20.03K |